NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
Press Release
Read More
Deep phenotyping and spatial interrogation of the NSCLC tumor microenvironment using the fully validated Next Generation MultiOmyx™ Platform
Literature
Read More
NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Press Release
Read More
NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
Press Release
Read More